These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 2547747)
61. Clinical efficacy of dirithromycin in acute exacerbations of chronic bronchitis. Sides GD J Antimicrob Chemother; 1993 Mar; 31 Suppl C():131-8. PubMed ID: 8478304 [TBL] [Abstract][Full Text] [Related]
62. Acute exacerbation of chronic bronchitis: what is the clinical significance of pathogenic bacteria in sputum cultures? Watanakunakorn C Chest; 2000 Dec; 118(6):1523-5. PubMed ID: 11115428 [No Abstract] [Full Text] [Related]
63. Comparative studies of azithromycin in skin and soft-tissue infections and sexually transmitted infections by Neisseria and Chlamydia species. Lassus A J Antimicrob Chemother; 1990 Jan; 25 Suppl A():115-21. PubMed ID: 2154430 [TBL] [Abstract][Full Text] [Related]
64. Clinical efficacy and tolerance of two new macrolides, clarithromycin and josamycin, in the treatment of patients with acute exacerbations of chronic bronchitis. Fraschini F J Int Med Res; 1990; 18(2):171-6. PubMed ID: 2140331 [TBL] [Abstract][Full Text] [Related]
65. A double-blind comparison of low-dose ofloxacin and amoxycillin/clavulanic acid in acute exacerbations of chronic bronchitis. Rademaker CM; Sips AP; Beumer HM; Hoepelman IM; Overbeek BP; Möllers MJ; Rozenberg-Arska M; Verhoef J J Antimicrob Chemother; 1990 Nov; 26 Suppl D():75-81. PubMed ID: 2286595 [TBL] [Abstract][Full Text] [Related]
66. Comparative efficacies of azithromycin and ciprofloxacin against experimental Salmonella typhimurium infection in mice. Butler T; Girard AE J Antimicrob Chemother; 1993 Feb; 31(2):313-9. PubMed ID: 8385094 [TBL] [Abstract][Full Text] [Related]
67. Clinical efficacy of dirithromycin versus miocamycin in the treatment of acute bronchitis or acute exacerbations of chronic bronchitis. Pozzi E J Antimicrob Chemother; 1993 Mar; 31 Suppl C():153-8. PubMed ID: 8478306 [TBL] [Abstract][Full Text] [Related]
69. The pharmacokinetics of azithromycin in human serum and tissues. Foulds G; Shepard RM; Johnson RB J Antimicrob Chemother; 1990 Jan; 25 Suppl A():73-82. PubMed ID: 2154441 [TBL] [Abstract][Full Text] [Related]
70. Azithromycin: the first of the tissue-selective azalides. Hoepelman IM; Schneider MM Int J Antimicrob Agents; 1995 May; 5(3):145-67. PubMed ID: 18611663 [TBL] [Abstract][Full Text] [Related]
71. The quinolones in chronic bronchitis. Davies BI; Maesen FP; Teengs JP; Baur C Pharm Weekbl Sci; 1986 Feb; 8(1):53-9. PubMed ID: 3960693 [TBL] [Abstract][Full Text] [Related]
72. A comparison of ampicillin, erythromycin and erythromycin with sulphametopyrazine in the treatment of infective exacerbations of chronic bronchitis. Willey RF; Gould JC; Grant IW Br J Dis Chest; 1978 Jan; 72(1):13-20. PubMed ID: 341951 [TBL] [Abstract][Full Text] [Related]
73. In vitro and in vivo intraleukocytic accumulation of azithromycin (CP-62, 993) and its influence on ex vivo leukocyte chemiluminescence. Bonnet M; Van der Auwera P Antimicrob Agents Chemother; 1992 Jun; 36(6):1302-9. PubMed ID: 1329619 [TBL] [Abstract][Full Text] [Related]
74. Azithromycin concentrations in sinus fluid and mucosa after oral administration. Karma P; Pukander J; Penttilä M Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):856-9. PubMed ID: 1662632 [TBL] [Abstract][Full Text] [Related]
75. The pharmacokinetics of azithromycin and their clinical significance. Lode H Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):807-12. PubMed ID: 1662623 [TBL] [Abstract][Full Text] [Related]